Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
4 minute read
  • Cannabis
  • Contracts
  • FDA
  • Global
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

Psyched: Biden’s Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More

By Lara Goldstein
December 18, 1:21 PM
Biden To Decide On Psychedelic Therapy Bill

ATAI

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap

Why Is COVID-19 Antibody Focused Invivyd Stock Trading Over 150% Higher Today?

By Vandana Singh
December 18, 12:55 PM
Invivyd Inc (NASDAQ: IVVD) shares are trading higher after the company released initial results from the ongoing CANOPY Phase 3 pivotal clinical trial of VYD222, a broadly neutralizing, half-life extended monoclonal antibody candidate, for the prevention of 

IVVD

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Small Cap

Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today?

By Vandana Singh
December 18, 12:47 PM
Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic castration-res

LNTH

Read More
1 minute read
  • Biotech
  • General
  • News

Ozempic’s Brain Impact Linked To Heart Disease Benefits In Study; Anti-Inflammatory Pathways In The Brain May Have Wide Effects; Findings Suggest GLP-1 Drugs May Help Treat Various Diseases’ – Bloomberg News

By Benzinga Newsdesk
December 18, 12:24 PM
https://www.bloomberg.com/news/articles/2023-12-18/ozempic-s-brain-impact-linked-to-heart-disease-benefits-

NVO

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Small Cap

Why Is Novo Nordisk’s Potential Obesity Drug Rival Structure Therapeutics Stock Tanking Today?

By Vandana Singh
December 18, 12:20 PM
Structure Therapeutics Inc (NASDAQ: GPCR) shares are trading lower after the company provided a comprehensive development program update for its highly selective oral GLP-1 

GPCR

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

GSK’s Jemperli Cancer Drug Hits Primary Goal In Endometrial Cancer Study

By Vandana Singh
December 18, 11:28 AM
GSK plc (NYSE: GSK) 

GSK

Read More
2 minute read
  • Biotech
  • General
  • News

Andelyn Biosciences Selected By Ultragenyx For Late-Stage Process Performance Qualification Manufacturing Of Novel Gene Therapy For Sanfilippo Syndrome

By Happy Mohamed
December 18, 10:38 AM
 Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced that it has been selected by Ultragenyx (NASDAQ:RARE) to

RARE

Read More
1 minute read
  • Equities
  • FDA
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks

Why Is Diagnostics Products Focused Biomerica Stock Trading Higher Today?

By Vandana Singh
December 18, 10:24 AM
Biomerica Inc (NASDAQ: BMRA) has received FDA 510(k) clearance for its Hp Detect Stool Antigen ELISA test, designed to detect the presence of the 

BMRA

Read More
1 minute read
  • FDA
  • News

Sysco And iFoodDS To Explore Flexible Network Solutions For FSMA 204 Food Traceability Rule Compliance

By Happy Mohamed
December 18, 10:05 AM
Sysco Corporation (NYSE:SYY), and iFoodDS announced a proof-of-concept project to explore solutions that enable Sysco and its diverse supplier base to capture, store, and share data required by the U.S. Food and Drug

SYY

Read More
4 minute read
  • Biotech
  • General
  • News

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B And MTAP Deletions

By Happy Mohamed
December 18, 10:04 AM
- Patient Pharmacodynamic Data Show Decrease in CDKN2A, CDKN2B, and PRMT5 Protein Levels -   - A Squamous Non-Small Cell Lung Cancer Patient with CDKN2B Deletion Achieved Marked Tumor Shrinkage after One Cycle

CYCC

Posts pagination

Previous 1 … 157 158 159 … 795 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service